Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer
Long-term safety and secondary efficacy endpoints in the ENGOT-OV16/NOVA phase III trial of niraparib in recurrent ovarian cancer Matulonis, U., Herrstedt, J., Oza, A., Mahner, S., Redondo, A., Berton, D., Berek, J., Lund, B., Marme, F., Gonzalez-Martin, A., Tinker, A., Ledermann, J., Benigno, B., Lindahl, G., Colombo, N., Li, Y., Gupta, D., Monk, B., Mirza, M. ACADEMIC PRESS INC ELSEVIER SCIENCE. 2021: S24-S25View details for Web of Science ID 000687070800039